PBPH

Portfolio Building Block World Pharma and Biotech

Stock NASDAQ – Stock Market Prices, News & Analysis

Fund or investment vehicle offering exposure to pharmaceutical and biotechnology companies worldwide.

$ 24.74
1.36 %

Portfolio Building Block World Pharma and Biotech

$ 24.74
1.36 %
PBPH

Fund or investment vehicle offering exposure to pharmaceutical and biotechnology companies worldwide.

Price history of Portfolio Building Block World Pharma and Biotech
Price history of Portfolio Building Block World Pharma and Biotech

Performance & Momentum

6 Months 0.10 %
1 Year 0.10 %
3 Years 0.10 %
5 Years 0.44 %

Strategic Analysis

Portfolio Building Block World Pharma and Biotech • 2026

PBPH is an investment fund dedicated to global exposure in the pharmaceutical and biotechnology sectors, combining geographical and sectoral diversification. It targets investors looking to capitalize on medical innovation and sustainable growth dynamics in global health.

Strengths
  • Broad international coverage of pharmaceutical and biotechnology companies
  • Access to a highly innovative sector with long-term growth opportunities
  • Positioning on strong themes such as global health and research
Weaknesses
  • Exposure to specific risks in the biotech and pharma sectors, particularly regulatory
  • Sensitivity to market cycles and volatility typical of sector-themed funds
Momentum

The moderate and stable momentum reflects a sustained but cautious interest, indicating a balance between attractive valuations and current sector uncertainties. This dynamic invites consideration of the product for medium-term diversification by providing targeted yet controlled exposure.

Similar stocks to Portfolio Building Block World Pharma and Biotech

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone